OSL — Oncosil Medical Balance Sheet
0.000.00%
- AU$23.03m
- AU$14.64m
- AU$0.58m
Annual balance sheet for Oncosil Medical, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 21 | 12.2 | 11.3 | 9.39 | 4.5 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2.81 | 1.18 | 0.908 | 1.29 | 1.44 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 23.9 | 13.6 | 12.7 | 11.2 | 6.33 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.138 | 0.531 | 0.325 | 0.239 | 0.39 |
Total Assets | 24.1 | 14.2 | 13.1 | 11.5 | 6.72 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.16 | 2.13 | 1.77 | 1.57 | 1.94 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 2.16 | 2.45 | 1.91 | 1.59 | 1.98 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 21.9 | 11.7 | 11.2 | 9.88 | 4.74 |
Total Liabilities & Shareholders' Equity | 24.1 | 14.2 | 13.1 | 11.5 | 6.72 |
Total Common Shares Outstanding |